Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 5,752,106	$ 2,977,713
Marketable securities	0	2,976,573
Accounts receivable, net of allowance for credit losses of $10,000, respectively	386,836	312,664
Prepaid expenses and other current assets	774,603	517,785
Inventories	3,329,101	2,638,186
Advances on contracts	1,250,953	1,371,548
Total current assets	11,493,599	10,794,469
Furniture, fixtures and equipment, net	12,989	10,024
Intangibles, net	162,105	178,636
Right of use assets finance lease	4,673	8,998
Right of use assets operating lease	307,724	355,235
Other assets	24,150	24,150
Total assets	12,005,240	11,371,512
Current liabilities:
Accrued expenses and other payables	1,070,276	1,511,717
Accrued expenses, related party	208,682	137,189
Accrued Liabilities noncontrolling interest	214,000	214,000
Current portion of finance lease liabilities	5,683	10,264
Current portion of operating lease liabilities	109,706	103,427
Total current liabilities	3,826,313	3,076,713
Non-current portion of finance lease liabilities	0	434
Non-current portion of operating lease liabilities	225,050	281,853
Total liabilities	4,051,363	3,359,000
Commitments and contingencies
Stockholders’ equity
Common stock, par value $0.001; authorized 100,000,000 shares; 77,227,714 shares issued and 77,194,381 shares outstanding as of June 30, 2024; 75,881,840 shares issued and 75,848,507 shares outstanding as of December 31, 2023;	77,228	75,881
Additional paid in capital	133,344,565	132,187,656
Accumulated deficit	(124,556,400)	(123,339,509)
Treasury stock, at cost, 33,333 shares	(911,516)	(911,516)
Total Milestone Scientific, Inc. stockholders' equity	7,953,877	8,012,512
Total liabilities and stockholders’ equity	12,005,240	11,371,512
Nonrelated Party [Member]
Current liabilities:
Accounts payable	1,403,137	689,604
Related Party [Member]
Current liabilities:
Accounts payable	$ 814,829	$ 410,512